Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and responseOk-Kyong Chaekal, Koen van Besien, Melissa M. Cushing et al.|Blood Advances|2020Cited by 5
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary OutcomesUsama Gergis, Koen van Besien, Emeline Masson Frenet et al.|Transplantation and Cellular Therapy|2018Cited by 4